Does Highly Active Antiretroviral Therapy Increase the Risk of Congenital Abnormalities in HIV-Infected Women?
Authors:
- Deven PatelDPDeven Patel
- Claire ThorneCTClaire Thorne
- Simona FioreSFSimona Fiore
- Marie-Louise NewellMNMarie-Louise Newell
- 1 September 2005
- journal article
- letter
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 40 (1) , 116-118
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Risk of Birth Defects Associated With Nelfinavir Exposure During PregnancyObstetrics & Gynecology, 2004
- Gender and race do not alter early-life determinants of clinical disease progression in HIV-1 vertically infected childrenAIDS, 2004
- Exposure to Antiretroviral Therapy in Utero or Early Life: the Health of Uninfected Children Born to HIV-Infected WomenJAIDS Journal of Acquired Immune Deficiency Syndromes, 2003
- Two-Dose Intrapartum/Newborn Nevirapine and Standard Antiretroviral Therapy to Reduce Perinatal HIV TransmissionA Randomized TrialJAMA, 2002